Zoetis beats profit estimates on strong demand for pet products [Yahoo! Finance]
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: Yahoo! Finance
Zoetis deals with vaccines, medicines and diagnostic solutions for animals and manufactures products for livestock and fish, which it markets in more than 40 countries. The company posted adjusted profit of $1.38 per share for the first quarter, beating analysts' average estimate of $1.34 per share, according to LSEG data. Shares of the company rose 4% to $163.52 in premarket trading. Zoetis had said in February it expects companion animal to be the primary growth driver in 2024, helped in part by strong demand for its osteoarthritis pain medication — Librela for dogs and Solensia for cats. The New Jersey-based company posted first-quarter revenue of $2.19 billion, compared with analysts' estimate of $2.13 billion. Revenue in its companion animal segment, which sells vaccines and medicines for dogs, cats and horses, rose 18% to $1.45 billion, also beating estimates of $1.37 billion. Zoetis attributed the rise in revenue to growth in its flea, tick and heartworm combinatio
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTSPR Newswire
- Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets – Hagens BermanGlobeNewswire
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the FirmAccesswire
- Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference Business Wire
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the FirmAccesswire
ZTS
Earnings
- 5/2/24 - Beat
ZTS
Sec Filings
- 5/8/24 - Form DEFA14A
- 5/7/24 - Form 144
- 5/6/24 - Form DEFA14A
- ZTS's page on the SEC website